Joanna M Ledingham1, Neil Snowden2, Ali Rivett3, James Galloway4, Zoe Ide3, Jill Firth2, Elizabeth MacPhie5, Ngianga Kandala6, Elaine M Dennison6, Ian Rowe3. 1. Rheumatology Department, Portsmouth Hospitals NHS Trust, Portsmouth Jo.ledingham@porthosp.mhs.uk. 2. Rheumatology Department, Pennine MSK Partnership, Oldham. 3. Clinical Affairs Department, British Society for Rheumatology. 4. Rheumatology Department, King's College Hospital, London. 5. Rheumatology Department, Lancashire Care NHS Foundation Trust, Preston. 6. MRC Lifecourse Epidemiology Unit, Southampton University, Southampton, UK.
Abstract
OBJECTIVES: A national audit was performed assessing the early management of suspected inflammatory arthritis by English and Welsh rheumatology units. The aim of this audit was to measure the performance of rheumatology services against National Institute for Health and Care Excellence (NICE) quality standards (QSs) for the management of early inflammatory arthritis benchmarked to regional and national comparators for the first time in the UK. METHODS: All individuals >16 years of age presenting to rheumatology services in England and Wales with suspected new-onset inflammatory arthritis were included in the audit. Information was collected against six NICE QSs that pertain to early inflammatory arthritis management. RESULTS: We present national data for the 6354 patients recruited from 1 February 2014 to 31 January 2015; 97% of trusts and health boards in England and Wales participated in this audit. Only 17% of patients were referred by their general practitioner within 3 days of first presentation. Specialist rheumatology assessment occurred within 3 weeks of referral in 38% of patients. The target of DMARD initiation within 6 weeks of referral was achieved in 53% of RA patients; 36% were treated with combination DMARDs and 82% with steroids within the first 3 months of specialist care. Fifty-nine per cent of patients received structured education on their arthritis within 1 month of diagnosis. In total, 91% of patients had a treatment target set; the agreed target was achieved within 3 months of specialist review in only 27% of patients. Access to urgent advice via a telephone helpline was reported to be available in 96% of trusts. CONCLUSION: The audit has highlighted gaps between NICE standards and delivery of care, as well as substantial geographic variability.
OBJECTIVES: A national audit was performed assessing the early management of suspected inflammatory arthritis by English and Welsh rheumatology units. The aim of this audit was to measure the performance of rheumatology services against National Institute for Health and Care Excellence (NICE) quality standards (QSs) for the management of early inflammatory arthritis benchmarked to regional and national comparators for the first time in the UK. METHODS: All individuals >16 years of age presenting to rheumatology services in England and Wales with suspected new-onset inflammatory arthritis were included in the audit. Information was collected against six NICE QSs that pertain to early inflammatory arthritis management. RESULTS: We present national data for the 6354 patients recruited from 1 February 2014 to 31 January 2015; 97% of trusts and health boards in England and Wales participated in this audit. Only 17% of patients were referred by their general practitioner within 3 days of first presentation. Specialist rheumatology assessment occurred within 3 weeks of referral in 38% of patients. The target of DMARD initiation within 6 weeks of referral was achieved in 53% of RA patients; 36% were treated with combination DMARDs and 82% with steroids within the first 3 months of specialist care. Fifty-nine per cent of patients received structured education on their arthritis within 1 month of diagnosis. In total, 91% of patients had a treatment target set; the agreed target was achieved within 3 months of specialist review in only 27% of patients. Access to urgent advice via a telephone helpline was reported to be available in 96% of trusts. CONCLUSION: The audit has highlighted gaps between NICE standards and delivery of care, as well as substantial geographic variability.
Authors: Jennifer H Humphreys; Suzanne M M Verstappen; Kimme L Hyrich; Jacqueline R Chipping; Tarnya Marshall; Deborah P M Symmons Journal: Ann Rheum Dis Date: 2012-09-03 Impact factor: 19.103
Authors: Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maya Buch; Gerd Burmester; Maxime Dougados; Paul Emery; Cécile Gaujoux-Viala; Laure Gossec; Jackie Nam; Sofia Ramiro; Kevin Winthrop; Maarten de Wit; Daniel Aletaha; Neil Betteridge; Johannes W J Bijlsma; Maarten Boers; Frank Buttgereit; Bernard Combe; Maurizio Cutolo; Nemanja Damjanov; Johanna M W Hazes; Marios Kouloumas; Tore K Kvien; Xavier Mariette; Karel Pavelka; Piet L C M van Riel; Andrea Rubbert-Roth; Marieke Scholte-Voshaar; David L Scott; Tuulikki Sokka-Isler; John B Wong; Désirée van der Heijde Journal: Ann Rheum Dis Date: 2013-10-25 Impact factor: 19.103
Authors: Joanna M Ledingham; Neil Snowden; Ali Rivett; James Galloway; Zoe Ide; Jill Firth; Elizabeth MacPhie; Ngianga Kandala; Elaine M Dennison; Ian Rowe Journal: Rheumatology (Oxford) Date: 2016-10-01 Impact factor: 7.580
Authors: Claire Barber; Diane Lacaille; Marc Hall; Victoria Bohm; Linda C Li; Cheryl Barnabe; James Rankin; Glen Hazlewood; Deborah A Marshall; Paul Macmullan; Dianne Mosher; Joanne Homik; Kelly English; Karen Tsui; Karen L Then Journal: BMJ Open Date: 2021-03-05 Impact factor: 2.692
Authors: Claire E H Barber; Orit Schieir; Diane Lacaille; Deborah A Marshall; Cheryl Barnabe; Glen Hazlewood; J Carter Thorne; Vandana Ahluwalia; Susan J Bartlett; Gilles Boire; Boulos Haraoui; Carol Hitchon; Edward Keystone; Diane Tin; Janet E Pope; Lisa Denning; Vivian P Bykerk Journal: Arthritis Care Res (Hoboken) Date: 2018-03-25 Impact factor: 4.794
Authors: Mark Yates; Katie Bechman; Elaine M Dennison; Alexander J MacGregor; Jo Ledingham; Sam Norton; James B Galloway Journal: Arthritis Res Ther Date: 2020-04-17 Impact factor: 5.156